Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.360
+0.050 (2.16%)
At close: May 29, 2026, 4:00 PM EDT
2.400
+0.040 (1.69%)
After-hours: May 29, 2026, 7:51 PM EDT
Caribou Biosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Caribou Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $12. The average 1-year stock price forecast is 408.47% higher than the current stock price, while the lowest is $4.00 (+69.49%) and the highest is $32 (+1,255.93%).
Price Target: $12 (+408.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caribou Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 7 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $6 | Buy | Maintains | $6 | +154.24% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $9 → $11 | Buy | Maintains | $9 → $11 | +366.10% | May 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $10 | Buy | Maintains | $10 | +323.73% | May 8, 2026 |
| Citi | Citi | Buy Maintains $8 | Buy | Maintains | $8 | +238.98% | May 8, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +450.85% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
10.99M
from 11.16M
Decreased by -1.49%
Revenue Next Year
12.92M
from 10.99M
Increased by 17.57%
EPS This Year
-1.27
from -1.59
EPS Next Year
-1.44
from -1.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.3M | 15.8M | ||||||
| Avg | 11.0M | 12.9M | ||||||
| Low | 9.7M | 11.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.3% | 43.3% | ||||||
| Avg | -1.5% | 17.6% | ||||||
| Low | -13.1% | 1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.85 | -1.39 | |||
| Avg | -1.27 | -1.44 | |||
| Low | -1.39 | -1.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.